Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Osamu, Muto"'
Autor:
Yoshinori Kagawa, Koji Ando, Mamoru Uemura, Jun Watanabe, Koji Oba, Yasunori Emi, Nobuhisa Matsuhashi, Naoki Izawa, Osamu Muto, Tatsuya Kinjo, Ichiro Takemasa, Eiji Oki
Publikováno v:
Annals of Gastroenterological Surgery, Vol 8, Iss 6, Pp 1067-1075 (2024)
Abstract Aim To evaluate the feasibility and safety of total neoadjuvant therapy with long‐course chemoradiotherapy followed by consolidation chemotherapy in Japanese patients with locally advanced rectal cancer. Methods This prospective, multicent
Externí odkaz:
https://doaj.org/article/3d67fb3ae60f4273881d57e185a2000d
Autor:
Daisuke Muraoka, Meng Ling Moi, Osamu Muto, Takaaki Nakatsukasa, Situo Deng, Chieko Takashima, Rui Yamaguchi, Shin-ichi Sawada, Haruka Hayakawa, Thi Thanh Ngan Nguyen, Yasunari Haseda, Takatoshi Soga, Hirokazu Matsushita, Hiroaki Ikeda, Kazunari Akiyoshi, Naozumi Harada
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-17 (2024)
Abstract Vaccine-induced T cells and neutralizing antibodies are essential for protection against SARS-CoV-2. Previously, we demonstrated that an antigen delivery system, pullulan nanogel (PNG), delivers vaccine antigen to lymph node medullary macrop
Externí odkaz:
https://doaj.org/article/4fe9413ee54f426598c15d2588d785e7
Publikováno v:
BMC Emergency Medicine, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Accurate identification of the cricothyroid membrane is crucial for successful cricothyrotomy; however, a manoeuvre that helps identify it both accurately and quickly remains unclear. The effectiveness of the so-called ‘bottom-u
Externí odkaz:
https://doaj.org/article/4b9beb07a28d447d9dc30ae0f9ca1cf4
Autor:
Michio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, Yasuyuki Kawamoto, Satoshi Yuki, Susumu Sogabe, Ayumu Hosokawa, Kentaro Sawada, Osamu Muto, Naoki Izawa, Koji Nakashima, Yoshiki Horie, Masataka Yagisawa, Shinya Kajiura, Takayuki Ando, Yosuke Mitsuhashi, Yu Sunakawa, Yasuka Kikuchi, Yoshito Komatsu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Although initial therapy with a parenteral anticoagulant is required before edoxaban, this strategy is frequently avoided in actual clinical practice because of its complexity. This study assessed the feasibility of edoxaban witho
Externí odkaz:
https://doaj.org/article/920bd0892d904f39b7d402794cf1198e
Autor:
Hiroshi Nakatsumi, Yoshito Komatsu, Tetsuhito Muranaka, Satoshi Yuki, Yasuyuki Kawamoto, Kazuaki Harada, Masayoshi Dazai, Miki Tateyama, Yusuke Sasaki, Takuto Miyagishima, Yasushi Tsuji, Masaki Katagiri, Michio Nakamura, Susumu Sogabe, Kazuteru Hatanaka, Takashi Meguro, Tomoe Kobayashi, Atsushi Ishiguro, Osamu Muto, Yoshiaki Shindo, Masahito Kotaka, Takayuki Ando, Ryo Takagi, Naoya Sakamoto, Yu Sakata
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe first-line chemotherapy for patients with RAS and BRAF wild-type metastatic colorectal cancer (mCRC) commonly involves cytotoxic regimens, such as FOLFOX and FOLFIRI, combined with epidermal growth factor receptor (EGFR) antibodies. Whe
Externí odkaz:
https://doaj.org/article/aab8f05946ed4eb79d1f6def13b45094
Autor:
Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, Michio Nakamura, Osamu Muto, Susumu Sogabe, Yoshiaki Shindo, Atsushi Ishiguro, Atsushi Sato, Yasushi Tsuji, Masayoshi Dazai, Hiroyuki Okuda, Takashi Meguro, Kazuaki Harada, Mari Sekiguchi, Kazufumi Okada, Yoichi M Ito, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
The Oncologist. 27(8):e642-e649
Background Ramucirumab is a human IgG1 monoclonal vascular endothelial growth factor receptor-2 antibody that inhibits tumor cell growth and affects the tumor cell microenvironment. We assessed the efficacy and safety of ramucirumab plus irinotecan c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cc69eba2d426282aed725eb5ff31f5
http://hdl.handle.net/2115/86546
http://hdl.handle.net/2115/86546
Autor:
Kazuaki Harada, Takahiro Yamamura, Osamu Muto, Michio Nakamura, Susumu Sogabe, Kentaro Sawada, Shintaro Nakano, Masataka Yagisawa, Tetsuhito Muranaka, Masayoshi Dazai, Miki Tateyama, Yoshimitsu Kobayashi, Sosuke Kato, Kazuteru Hatanaka, Yasuyuki Kawamoto, Satoshi Yuki, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 4
Pages: 1596
Volume 12
Issue 4
Pages: 1596
The effects of UGT1A1 gene polymorphisms or prior irinotecan treatment on treatment outcomes of nanoliposomal-irinotecan plus 5-fluorouracil/leucovorin (nal-IRI+5-FU/LV) in patients with unresectable pancreatic ductal adenocarcinoma (PDAC) are not es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58106ec075031a2c6524330ed102f519
Autor:
Taichi Yoshida, Koji Fukuda, Kentaro Takahashi, Fuminori Ono, Yuko Yoshida, Kyoko Nomura, Osamu Muto, Hiroyuki Shibata, Kazuhiro Shimazu, Daiki Taguchi, Kengo Shibuya
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND Angiogenesis inhibitors (AIs) combination with cytotoxic chemotherapy is a promising treatment for patients with colorectal cancer (CRC). Aflibercept (AFL) is an option for second-line treatment of CRC, according to the ‘VELOUR’ trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a590f6f5eb3452727adafc0a1c87ff
http://europepmc.org/articles/PMC8040061
http://europepmc.org/articles/PMC8040061
Autor:
Hideo Nishimura, Susumu Tamakawa, Osamu Muto, Ai Takasoe, Kenji Takahashi, Shiro Yokohama, Fuminori Hirano, Hiroki Saito
Publikováno v:
Internal Medicine
A 26-year-old man was admitted to our hospital due to upper abdominal pain. He had previously been diagnosed with gastroduodenal ulcer at 23 and 25 years old and had been treated with proton-pump inhibitors. Endoscopic hemostasis and a biopsy were pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955667ecf2dd9ccaecb2c9cc3481f1fd
https://doi.org/10.2169/internalmedicine.4483-20
https://doi.org/10.2169/internalmedicine.4483-20
Autor:
Osamu Muto, Masahiro Inoue, Yuko Hiroshima, Hiroyuki Shibata, Maya Suzuki, Aki Nishijima-Matsunobu, Katsuhiko Enomoto, Hiroshi Nanjo, Yohei Yamamoto, Yasufumi Omori
Publikováno v:
Pathology International. 70:171-178
Desmoplastic small round cell tumor (DSRCT) is a rare aggressive malignant tumor. It is a refractory tumor and the median overall survival is very short. We report two autopsy cases of DSRCT, both of which were already advanced and metastasized at th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c147f3f32a3a0d33b4eaeca158a32307
https://doi.org/10.1111/pin.12897
https://doi.org/10.1111/pin.12897